Skip to main content

Sage Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Thursday, February 16, 2023 at 8:00 a.m. ET to review fourth quarter and full year 2022 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.61
+2.66 (1.22%)
AAPL  260.00
+1.55 (0.60%)
AMD  235.23
+5.00 (2.17%)
BAC  51.70
+0.60 (1.18%)
GOOG  255.20
+2.67 (1.06%)
META  735.97
+2.56 (0.35%)
MSFT  523.25
+2.71 (0.52%)
NVDA  182.70
+2.42 (1.34%)
ORCL  282.68
+10.02 (3.67%)
TSLA  445.28
+6.31 (1.44%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.